Associations between local acidosis induced by renal LDHA and renal fibrosis and mitochondrial abnormalities in patients with diabetic kidney disease

被引:19
作者
Lee, Dae-Yeon
Kim, Ji-Yeon
Ahn, Eunyong
Hyeon, Jin Seong
Kim, Gyu-Hee
Park, Keon-Jae
Jung, Youngae
Lee, Yoo-Jeong
Son, Mi Kyoung
Kim, Seung Woo
Han, Sang Youb
Kim, Jae-Hong
Roh, Gu Seob
Cha, Dae Ryong [3 ]
Hwang, Geum-Sook [2 ]
Kim, Won-Ho [1 ]
机构
[1] Korea Natl Inst Hlth, Div Cardiovasc Dis Res, Cheongju, South Korea
[2] Korea Basic Sci Inst, Western Seoul Ctr, Seoul, South Korea
[3] Korea Univ Ansan Hosp, Dept Internal Med, Ansan, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
METABOLIC-ACIDOSIS; AEROBIC GLYCOLYSIS; PROGRESSION; NEPHROPATHY; TARGET; FAMILY; ACTIVATION; MECHANISMS; SIGNATURE; PATHWAYS;
D O I
10.1016/j.trsl.2022.06.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
During the progression of diabetic kidney disease (DKD), renal lactate metabolism is rewired. The relationship between alterations in renal lactate metabolism and renal fibrosis in patients with diabetes has only been partially established due to a lack of biopsy tissues from patients with DKD and the intricate mechanism of lactate homeostasis. The role of lactate dehydrogenase A (LDHA)-mediated lactate generation in renal fibrosis and dysfunction in human and animal models of DKD was explored in this study. Measures of lactate metabolism (urinary lactate levels and LDHA expression) and measures of DKD progression (estimated glomerular filtration rate and Wilms' tumor-1 expression) were strongly negatively correlated in patients with DKD. Experiments with streptozotocin-induced DKD rat models and the rat renal mesangial cell model confirmed our findings. We found that the pathogenesis of DKD is linked to hypoxia-mediated lactic acidosis, which leads to fibrosis and mitochondrial abnormalities. The pathogenic characteristics of DKD were significantly reduced when aerobic glycolysis or LDHA expression was inhibited. Further studies will aim to investigate whether local acidosis caused by renal LDHA might be exploited as a therapeutic target in patients with DKD.
引用
收藏
页码:88 / 109
页数:22
相关论文
共 50 条
  • [21] Alterations of Renal Function in Patients with Diabetic Kidney Disease: A BOLD and DTI Study
    Wei, Xiaobao
    Hu, Runyue
    Zhou, Xiaoli
    Ni, Lihua
    Zha, Dongqing
    Feng, Huiling
    Xu, Haibo
    Wu, Xiaoyan
    [J]. COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [22] Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys
    Lee, Eun-Jung
    Kang, Min-Kyung
    Kim, Dong Yeon
    Kim, Yun-Ho
    Oh, Hyeongjoo
    Kang, Young-Hee
    [J]. NUTRIENTS, 2018, 10 (07):
  • [23] Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease
    Wang, Xiangyu
    Zhang, Huijie
    Zhang, Qian
    Guan, Meiping
    Sheng, Shuyue
    Mo, Wei
    Zou, Mengchen
    Li, Jimin
    Bi, Jianlu
    Tang, Xianyu
    Zeng, Huiyan
    He, Jiali
    Xu, Gugen
    Li, Ping
    Xue, Yaoming
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (10) : 806 - 814
  • [24] Supplemented Gegen Qinlian Decoction Formula attenuates podocyte mitochondrial fission and renal fibrosis in diabetic kidney disease by inhibiting TNF-α-mediated necroptosis, compared with empagliflozin
    Wang, Yu
    Yu, Lu
    Li, Yajing
    Cha, Siyu
    Shi, Lijing
    Wang, Jinlong
    Ge, Fengfeng
    Huang, Chubo
    Huang, Huang
    Tu, Yue
    Wan, Yigang
    Shen, Shanmei
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2024, 334
  • [25] Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
    Navarro-Gonzalez, Juan F.
    Mora-Fernandez, Carmen
    Muros de Fuentes, Mercedes
    Chahin, Jess
    Mendez, Maria L.
    Gallego, Eduardo
    Macia, Manuel
    del Castillo, Nieves
    Rivero, Antonio
    Getino, Maria A.
    Garcia, Patricia
    Jarque, Ana
    Garcia, Javier
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (01): : 220 - 229
  • [26] Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
    Saribas, Gulistan Sanem
    Yildiz, Halime Tozak
    Gorgulu, Ozkan
    [J]. DUZCE MEDICAL JOURNAL, 2022, 24 (03) : 321 - 327
  • [27] Focus on podocytes: diabetic kidney disease and renal fibrosis - a global bibliometric analysis (2000-2024)
    An, Dong-Yang
    Tan, Jun
    Lu, Yan-Dan
    Wen, Ze-Huai
    Bao, Yi-Ni
    Yao, Zhou-Hui
    Chen, Zi-Yan
    Wang, Ping-Ping
    Zhou, Wei
    Yang, Qiao
    Hao, Min
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease
    Li, Jinxiang
    Yue, Shuling
    Fang, Jingwen
    Zeng, Junling
    Chen, Siqi
    Tian, Jianwei
    Nie, Sheng
    Liu, Xiaoting
    Ding, Hanying
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 : 488 - 499
  • [29] TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease
    Du, Yunxia
    Wu, Ming
    Song, Shan
    Bian, Yawei
    Shi, Yonghong
    [J]. RENAL FAILURE, 2024, 46 (01)
  • [30] Disruption of Renal Tubular Mitochondrial Quality Control by Myo-Inositol Oxygenase in Diabetic Kidney Disease
    Zhan, Ming
    Usman, Irtaza M.
    Sun, Lin
    Kanwar, Yashpal S.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (06): : 1304 - 1321